Antiphospholipid syndrome (Q39599): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Síndrome antifosfolípide, também conhecida como síndrome de Hughes, é uma condição autoimune sistêmica caracterizada pela presença de anticorpos antifosfolipídicos (aPL) no soro de pacientes com eventos trombóticos e/ou complicações recorrentes na gravidez. | |||
| description / en | description / en | ||
Antiphospholipid syndrome, also known as Hughes syndrome, is a systemic autoimmune condition characterised by the presence of antiphospholipid antibodies (aPL) in the serum of patients with thrombotic events and/or recurrent pregnancy complications. | |||
Revision as of 05:04, 13 August 2026
Antiphospholipid syndrome, also known as Hughes syndrome, is a systemic autoimmune condition characterised by the presence of antiphospholipid antibodies (aPL) in the serum of patients with thrombotic events and/or recurrent pregnancy complications.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A45 |
||
| English | Antiphospholipid syndrome |
Antiphospholipid syndrome, also known as Hughes syndrome, is a systemic autoimmune condition characterised by the presence of antiphospholipid antibodies (aPL) in the serum of patients with thrombotic events and/or recurrent pregnancy complications. |
